References
- Wang M. D., Seippel L., Purdy R. H., Blackstrom T. Relationship between symptom severity and steroid variation in women with premenstrual syndrome. J. Clin. Endocrinol. Metab. 1996; 81: 1076–1082
- Toddywala R. D., Ulman K., Walters P., Chien Y. W. Effect of physicochemical properties of adhesive on the release, skin permeation and adhesiveness of adhesive-type transdermal drug delivery systems containing silicone-based pressure sensitive adhesives. Int. I. Pharm. 1991; 76: 77–89
- Bodde H. E., Kruithof M. A. M., Brusse J., Koerten H. K. Visualisation of normal and enhanced HgCl2 transport through human skin in vitro. Int. J. Pharm. 1989; 53: 13–24
- Valenta C., Almasi-Szabo I. In vitro diffusion studies of ketoprofen transdermal therapeutic systems. Drug Dev. Ind. Pharm. 1995; 21: 1799–805
- Strieker H. In vitro investigation of drug availability in the gastrointestinal tract. Drugs Made Germ. 1970; 13: 35–42
- Baker R. Controlled release: mechanisms and rates. Controlled Release, Biologically Active Agents, A. C. Tanquari, R. E Lacey. Plenum, New York 1974; 23–71
- DE 3902013 Al Patent, Germany, 1990